Summary. Shiga toxin and Shiga-like toxins (SLTs, syn. Verotoxins) are currently detected by tissue culture assays that are expensive, time-consuming and require specialised facilities and experienced personnel. We have developed a rapid method to detect Shiga toxin and SLT-I (Verotoxin 1) based on their binding to globotriosyl ceramide (Gb,). Bound toxin was then detected by an enzyme-linked immunosorbent assay (ELISA) with monoclonal antibodies. The direct detection of cytotoxins from pure culture plates and from a mixed bacterial culture was studied. Using polymyxin extraction (0.1 g/L, 30 min, 37°C) and Gb3-based ELISA we detected toxin from reference strains Shigella dysenteriae 1 strain 60R (Shiga toxin) and Escherichia coli 026: H11 strain H30 (SLT-I), and from clinical isolates of E. coli 0157 : H7 and 026: H11 (both SLT-I) from 11 patients with diarrhoea, haemorrhagic colitis or haemolytic uraemic syndrome. Toxin production by these strains was confirmed by a radiolabelled HeLa cell assay and the structural genes were detected by DNA hybridisation. The Gb3-based ELISA could detect SLT-I in extracts of a mixed culture even when the toxin-positive strains represented only 1% of the mixture. No cross-reactivity was found with bacteria that produce other cytotoxins, such as other E. coli and Shigella, Salmonella, Aeromonas and Campylobacter spp.
Introduction
Enteric bacteria that produce cytotoxins have been recognised increasingly as important causes of human disease.' They can cause diarrhoea or haemorrhagic colitis,293 and are thought to play a major pathogenic role in the haemolytic-uraemic syndrome (HUS) and thrombotic thrombocytopenic p~r p u r a .~-~ The cytotoxins implicated in these diseases include Shiga toxin, and the closely related Shiga-like toxins (SLTs), also known as Verotoxins, produced by Escherichia ~o l i .~-' At least two immunologically distinct toxins, SLT-I and SLT-I1 (Verotoxins 1 and 2), have been defiped. ' ' 9 SLT-I is neutralised by antibodies against Shiga toxin, to which it is virtually identical; there is only a three-nucleotide difference, resulting in a single amino acid difference, between the two toxins. Although SLT-I1 is immunologically distinct, this family of toxins is very similar in structure, mechanism of action, binding receptor and biological activities. 14-18 A variant of SLT-11, which is produced by E. coli strains associated with oedema disease in pigs" or human HUS,20 has been defined, cloned and sequenced. '
Detection of these cytotoxins in the routine clinical laboratory presents considerable difficulty. Toxins are usually detected by their ability to cause cytopathic effects in several cell lines. Radiolabelled DNA probes8* 2 1 are still not widely used. Detection of the toxins by enzyme-linked immunosorbent assay (ELISA) has been r e~o r t e d .~~-~~ We have described a rapid and sensitive assay to detect Shiga toxin and SLT-I based on binding to globotriosyl ceramide (Gb,). 2 5 However, preparation of suitable bacterial specimens required growth of cultures for 48 h and subsequent sonication-a prolonged and cumbersome extraction procedure. Since polymyxin extraction has been shown to be effective in releasing high levels of toxins from the periplasmic space of gram-negative bacteria,26v 2 7 it may provide a simpler extraction procedure. Furthermore, the need to examine individual colonies presents problems, because cytotoxinproducing bacteria are typically presented in low numbers in stool samples of patients with diarrhoea and, in particular, HUS. The proportion of cyto-toxin-producing colonies is often only 5-2OX4 or even lower. 28 The objectives of the present study were to evaluate the efficacy of a Gb3-based ELISA for detection of Shiga toxin and SLT-I released by polymyxin extraction, both from bacteria grown on various pure culture plates and, most importantly, directly from a mixed bacterial culture. Results of Gb3 ELISA were compared with the quantitative radiolabelled HeLa cell cytotoxicity assay, 299 30 and with detection of the structural genes for toxin production by DNA hybridisation.8
Materials and methods

Bacteria
Three reference bacterial strains that produce Shiga toxin and SLT-I were used initially for developing the extraction procedure and the assay : Shigellu dysenteriue serotype 1 strain 60R (Shiga toxin); E. coli serotype 026: H11, strain H30 (SLT-I), originally described by J. Konowalchuk;' and E. coli serotype 0157 : H7 (SLT-I), provided by J. Mathewson, who originally obtained the strain from R. Wilson, E. coli Reference Center, Pennsylvania State University. For specificity studies, other reference strains were used: E. coli K-12, strain C600 (a non-producer of cytotoxin); lysogenic E. coli K-12, strain C600 (933w) (SLT-11), kindly provided by A. D. O'Brien, Uniformed Services University of the Health Sciences, Bethesda, MD; and E. coli serotype 078:H11, strain H 10407 (heat-labile and heat-stable enterotoxin). Other bacteria examined included 40 isolates of Shigellu ~p p . ,~ 56 pathogenic and 10 nonpathogenic E. coli strain^,^' 52 Salmonella isolates,31 10 of Aeromonus ~p p . ,~* and 20 of Cumpylobucter spp. The E. coli strains included 14 isolates of E. coli serotype 0157: H7 from patients with haemorrhagic colitis, diarrhoea or HUS and three isolates of E. coli serotype 026: H11 from patients with diarrhoea.
Preparation of polymyxin extracts
Bacteria were grown on charcoal-yeast extract (CYE), blood and MacConkey agar plates, incubated overnight at 37°C. Polymyxin B (Sigma) was diluted in phosphatebuffered saline (PBS; 0.2 M sodium phosphate, 0.2 M potassium phosphate) to the desired concentration. To determine the optimal polymyxin B extraction procedure, bacterial cells were incubated with polymyxin B concentrations of 0, 0.01, 0.1, 0.2, 0.5, 1 or 2 g/L for periods of 2, 5, 10, 20, 30 or 60 min. For these experiments, E. coli 026:Hll strain H30, grown overnight on CYE, blood or MacConkey agar, was suspended in PBS to obtain a stock suspension of c. lo' cfu/ml and 1-ml volumes were placed in Eppendorf tubes and centrifuged in a microcentrifuge for 5 min. Cell pellets were resuspended in PBS containing the range of concentrations of polymyxin B and incubated in a water bath at 37°C for the test periods.
Samples were then centrifuged (5min) again and the supernates were sterilised by membrane filtration (pore size, 0.22 pm) and assayed for cytotoxicity. Protein concentration was determined by the Bio-Rad assay (BioRad Laboratories, Richmond, CA) with bovine serum albumin (BSA) as a standard. Assays were performed in duplicate and repeated at least three times. Control samples with polymyxin only were treated and assayed simultaneously. After these experiments, a standard extraction procedure was used with incubation for 30 min in polymyxin B 0.1 g/L.
Detection of Shiga toxin and SLT-I in bacteria grown in pure culture S. dysenteriue 1 strain 60R (Shiga toxin) and E. coli 026 : H11 strain H30 (SLT-I) were grown overnight on CYE, blood and MacConkey agar plates. A loopful (0.001-ml loop) of confluent bacterial growth was suspended in Eppendorf tubes containing 0.25 ml of polymyxin B 0-1 g/L in PBS. After incubation for 30 min at 37"C, samples were processed as above. To compare the yields obtained by sonic extraction and by polymyxin extraction, 1-ml samples of a stock suspension of E. coli H30 ( lo' cfu/ml in PBS) were extracted by polymyxin (as above) or by sonicati~n,~' and the amounts of cytotoxin obtained were measured. Negative control reference strains were grown, extracted and assayed simultaneously.
Detection of SLT-I from a mixed culture E. coli 026:Hll strain H30 and E. coli K-12 strain C600 were each grown overnight on CYE plates, washed in PBS and resuspended in PBS to a final concentration of lo' cfu/ml. Appropriate volumes of the two suspensions were mixed to obtain mixtures in which the proportion of E. coli H30 was 1 , 5,10,30 or 50%. Controls were pure suspensions of E. coli H30 and E. coli C600. Each mixture (100 pl) was plated on CYE agar and incubated overnight. A loopful of confluent bacterial growth from each mixture was suspended in an Eppendorf tube containing 0.25 ml of polymyxin B 0.1 g/L in PBS, incubated for 30 min at 37°C and processed as above.
Preparation ofpurijied Shiga toxin
Purified Shiga toxin was used in titration curves to determine the amount of toxin obtained by the extraction procedures. Toxin was purified from a sonic extract of S. dysenteriae serotype 1 strain 60R by chromatography with an Affi-Gel Blue column, chromatofocusing, and a hydroxylapatite column, as described previ~usly.~' The purified toxin had a specific activity of 107'3 50% cytotoxic doses (CDSO)/mg of protein.
Preparation of anti-Shiga toxin serum
Rabbit antishiga toxin serum, which also neutralised SLT-I, was obtained by repeated injections of formalde-hyde-treated purified Shiga toxin (100 pg/dose) as previously described.'
Gb3 ELZSA
The assay was performed as described previously. 2 5 Gb3 (Supelco, Bellefonte, PA) was diluted in chloroform:methanol (2: 1) to a concentration of 5 pg/ml and inoculated (100 pl/well) on to polyvinyl chloride microtitration plates (Dynatech Laboratories, Inc., Alexandria, VA). Plates were left uncovered overnight so that the diluent evaporated and Gb3 attached to the plates. After blocking with BSA (50 g/L, 200 pl/well, 1 h), test samples were added (100 pl/well, 1 h). Bound toxin was detected by monoclonal antibodies and peroxidase-conjugated rabbit anti-mouse antibodies as described previously. 25 Reproducibility of the extraction procedure and the assay was determined by duplicate testing. Sensitivity was determined by titration with purified Shiga toxin and comparing the readings with those obtained by polymyxin extraction of reference strains that produce Shiga toxin or SLT-I. Specificity was determined by examining crossreactivity with polymyxin extracts of well characterised bacterial strains that produce enterotoxins (E. coli H10407), SLT-I1 (E. coli C600 [933w]) or were cytotoxin non-producers (E. coli C600), and of various other cytotoxin-producing bacterial isolates (table) .
Cytotoxicity and neutralisation assays
Quantitative cytotoxic activity was determined by overnight incubation of cell-free toxin preparations with [ H3] thymidine-labelled HeLa cells as described previo~s l y . *~ Radioactivity of attached viable cells was counted and results were expressed as a percentage of HeLa cell survival in comparison with control wells without toxin. The CD5O was calculated from the linear regression of the percentage of HeLa cell survival uersus the log,, toxin dilution.' Neutralisation was studied by pre-incubation of the toxin for 4 h at 37°C with rabbit anti-Shiga toxin serum or rabbit non-immune serum (control) followed by determination of cytotoxicity with radiolabelled HeLa cells as described above.
DNA hybridisation studies
The DNA probe for SLT-I described by J. W. Newland and R. J. Neil1 (Walter Reed Army Institute of Research, Washington, DC) was used. The probe is a 1-142-kb BarnHI fragment of the recombinant plasmid pJN37-19, cloned from E. coli bacteriophage 933J.34 As Shiga toxin and SLT-I differ in only three nucleotides, the SLT-I probe also hybridises with Shiga toxin-producing organisms. The probe was extracted from low temperature gelling agarose and labelled by nick translation with 32P-labelled 5'-dCTP (Dupont, NEM Research Products, Boston, MA). Bacterial colonies were transferred to Whatman 541 filter papers, lysed as described previo u~l y ,~~ and hybridised under stringent conditionsformamide SO%, 42"C, 2 x SSC (SSC is 0.5 M NaCl+ 0.015 M sodium citrate), 18 h. The following positive and negative control strains were placed on each filter: S. dysenteriue serotype 1 strain 60R, E. coli 026 : H 1 1 strain H30, E. coli C600 (933w) and E. coli C600.
Results
Polymyxin B extraction
In experiments to optimise the conditions of our novel method of polymyxin extraction, which included direct inoculation from primary plates to polymyxin suspension and detection by Gb3 ELISA, the amounts of Shiga toxin and SLT-I released increased with increasing concentrations of polymyxin (0-0-1 g/L); a plateau of release was reached at 0.1 g/L. With this concentration of polymyxin, optimal release of cytotoxin was achieved by incubation for 10-60 min. In subsequent experiments, the standard extraction conditions used were polymyxin 0.1 g/L and incubation for 30 min at 37°C.
Detection of cytotoxin from pure cultures
Shiga toxin and SLT-I were detected by standard polymyxin extraction and Gb3 ELISA from pure cultures on agar media. Positive results were obtained with S . dysenteriae 1 strain 60R (Shiga toxin), E. coli 026: H11 strain H30 (SLT-I) and E. coli 0157:H7 (SLT-I). There was no crossreactivity with E. coli 078:Hll H10407 (enterotoxin), E. coli C600 (933w) (SLT-11) or E. coli C600 control strains examined simultaneously. The range of readings (OD490) of these negative-control reference strains was 0.01-0.04 (mean 0.03 SD 0.01). Readings of 2 0.1 were considered to be positive results. According to the titration curve, this reading represented 0.2-0-5 ng of purified Shiga toxin per well. Positive results were obtained with 1 1 clinical isolates of E. coli 0 1 57 : H7 or E. coli 026 : H11 from patients with haemorrhagic colitis, diarrhoea or HUS. None of the polymyxin extracts of various other cytotoxin-producing bacteria, including other strains of Shigella, pathogenic and non-pathogenic E. coli, Salmonella, Aeromonas and Campylobacter showed cross-reactivity in the assay (table) .
Comparison of polymyxin and sonic extraction
In parallel tests with the same number of bacteria from a stock suspension, the yields of toxin from polymyxin-treated and sonicated cells were com-S. ASHKENAZI AND T. G. CLEARY (25) pared. Polymyxin treatment gave lower OD readings--65-90% of these obtained with sonicated bacteria (fig. 1 a) . Similar results were obtained with bacteria grown on CYE, blood and MacConkey agars. However, when readings were translated into amounts of toxin (pg)/mg of bacterial protein (specific activity), the amounts of toxin extracted were five-fold higher with polymyxin treatment than with sonication ( fig. 1 b) .
Detection of SLT-I from mixed culture
Gb3 ELISA was used to detect SLT-I in polymyxin extracts of a mixed culture of SLT-I-positive and -negative strains. Positive results were obtained when the proportion of the SLT-I-positive strain (E. coli H30) was as low as 1% ( fig. 2) . A plateau was reached when the SLT-I-positive strain was c. 10% of the mixture. Pure growth of the toxinnegative strain (E. coli C600) gave negative results under the same experimental conditions.
Correlation with HeLa cell cytotoxicity assay and with DNA hybridisation
The cell-free polymyxin extracts were examined for cytotoxicity. The cut-off point of the assay (OD490 0.1) corresponded to about 10-30 CD50.
Extracts of control strains that gave positive results in the Gb3 ELISA, whether from pure or mixed cultures, were cytotoxic in the radiolabelled HeLa cell assay, and the cytotoxicity was neutralised by rabbit antiserum to Shiga toxin. Extracts of negative control strains were not cytotoxic. In tests with polymyxin extracts of other bacteria, strains that gave positive results for Shiga toxin or SLT-I (neutralised by rabbit antiserum to Shiga toxin) in the cytotoxicity assay or hybridised with the DNA probe for SLT-I, also gave positive results in the Gb3 ELISA. Polymyxin extracts that gave negative results in the cytotoxicity assay (no neutralisation with the anti-Shiga toxin serum) and in DNA hybridisation also gave negative results in the Gb3 ELISA (table). 
Discussion
Several approaches have been used for the diagnosis of cytotoxin-related diarrhoea1 disease and HUS. Initial attempts have concentrated on isolating E. coZi serotype 0 1 57: H7 by culture of MacConkey-sorbitol agar and on developing rapid diagnostic tests.36' 37 However, although E. coZi 0 1 57 : H7 is the most frequent serotype associated with haemorrhagic colitis and HUS, many other serotypes are involved. Therefore, the diagnostic approach should be directed toward detection of either cytotoxin-producing organisms or free cytotoxin activity. Detection of the genes encoding the relevant toxins in bacterial cells by radiolabelled DNA probes, either restriction fragments'. 34 or synthetic oligonucleotide probes,21 has been used effectively, but concern over handling radioactive materials may make them unsuitable for routine use in a clinical diagnostic laboratory.
Detection of cytotoxins from bacterial isolates or stool extracts is usually based on morphological changes (cytopathic effect) in HeLa or Vero cells. These assays take several days and require facilities for and experience with tissue cultures. Neutralisation studies to identify the toxin are sometimes difficult to interpret due to variable cell and because the sensitivity of various cell lines to cytotoxins varies significantly. ' Simple and rapid assays are needed for routine detection of cytotoxins.
Rapid ELISA methods to detect Shiga toxin and SLTs by binding to monoclonal antibod or to the toxin receptor have been 38 Th eY seem to be sensitive and specific and can facilitate cytotoxin detection. However, toxin detection is usually based on examination of individual colonies. This may present a significant problem because the proportion of cytotoxin-producing colonies in stool samples from patients with diarrhoea, and especially with HUS, may be d
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28 Therefore many colonies must be screened, which is cumbersome and impractical for clinical laboratories. Downes etal. used ELISA to detect cytotoxins in stool extracts, but they were unable to detect SLT-I because it was present in small q u a n t i t i e~.~~ Polymyxin extraction has been used to release Shiga toxin and SLTs from Shigella and E. coli strains;26'27 the toxin released was similar to that obtained by sonic extraction. 26 Polymyxin extraction of colony sweeps has been used successfully to detect cytotoxins from a mixed culture.27 However, although the extraction procedure was rapid and simple, colony sweeps were inoculated into broth and incubated for 5 h, and the cytotoxicity assay was based on morphological changes in Vero cells after 72 h, so that rapid diagnosis was not achieved.
In this study, we used polymyxin extraction, but attempted to detect cytotoxin directly from bacterial growth on readily available culture media by a rapid and simple receptor binding assay (Gb3 ELISA). The optimal conditions for polymyxin extraction directly from culture plates were similar to those described previously for extraction from bacteria grown in broth26927 and the standard extraction conditions used were polymyxin 0.1 g/L, for 30 min at 37°C.
We have shown that polymyxin extraction of bacterial growth from agar plates and Gb3 ELISA may be useful in the diagnosis of infections with bacteria that produce Shiga toxin and SLT-I. The sensitivity was surprisingly high; cytotoxin was detected in polymyxin extracts of a mixed culture when the proportion of the cytotoxin-producing strain was as low as 1%. This high sensitivity is probably because of the small volume (0.25 ml) in which bacteria were suspended and optimal condi-tions for polymyxin extraction. The assay was very specific-no cross-reactivity was found with enterotoxins, SLT-I1 or other cytotoxin-producing organisms, including other Shigella or E. coli strains and Salmonella, Campylobacter or Aeromonas strains. These results were in agreement with a radiolabelled cytotoxicity assay with neutralisation by specific antiserum, and with DNA hybridisation tests for the structural genes for toxin production. As Gb3 is also the binding receptor of SLT-II,39 the latter toxin may be detected also by the same method with appropriate antibodies to SLT-11. It would be very useful if polymyxin extraction and plates precoated with Gb3 could be used to detect both toxins, with specific identification of bound toxin by different anti bodies.
The sensitivity of our assay was 0.2 ng of purified toxin per well, similar to that described by Downes et al.,24 but lower than that described in two other assays;24938 it correlates with c. 10-30 CD50 in the HeLa cell cytotoxicity assay. Although Gb3 ELISA is slightly less sensitive than the cytotoxicity assay, it is specific, rapid, and easier to perform and interpret. The slightly lower sensitivity did not prevent detection of toxin from mixed culture, even when the proportion of the toxin-positive strain was only 1%. Low level cytotoxin-producing strains may not be detected by this assay, but their relevance to human disease is questionable.
Rapid and simple extraction and detection methods are necessary for routine use in clinical laboratories. They should be useful in large scale epidemiological studies of cytotoxin-related infections. Early diagnosis of these infections may be helpful in controlling person-to-person transmission and evaluating the efficacy of various therapeutic measures on the course of cytotoxin-related diarrhoea1 disease and on the development of HUS. 
